PATIENT ALERT: Masks are now optional in our VOA offices. If you are immunocompromised or feeling ill, masking is strongly encouraged. CLICK HERE for more details​​​​​​.
CLICK HERE regarding the Change Healthcare update.

Clinical Research & Trials

USO 22090

AN OPEN-LABEL MULTICENTER PHASE 1b-2 STUDY OF ELACESTRANT IN COMBINATION WITH ABEMACICLIB IN WOMEN AND MEN WITH BRAIN METASTASIS FROM ESTROGEN RECEPTOR POSITIVE, HER-2 NEGATIVE BREAST CANCER (ELECTRA) (ELA-0121)

 

Disease Types: Breast Cancer Research

Available at: